phase readout

NCT05934838: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

ACTIVE_NOT_RECRUITINGupdated 20d ago

community read0 votes

Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma

view source ↗

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ctgov

last refreshed 12m ago

Found something off?